Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：6.244 Date：2020-02-15

Frontiers in Oncology

The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug

Products： EP013、 EQ001
IF：6.244 Date：2022-01-14

Frontiers in Oncology

Bioinformatics, Molecular Docking and Experiments In Vitro Analyze the Prognostic Value of CXC Chemokines in Breast Cancer

Products： EP013、 EQ001
IF：6.244 Date：2021-09-15

Frontiers in Oncology

CircPTK2 Suppresses the Progression of Gastric Cancer by Targeting the MiR-196a-3p/AATK Axis

Products： EQ003
IF：6.222 Date：2021-09-24

Translational Psychiatry

proBDNF expression induces apoptosis and inhibits synaptic regeneration by regulating the RhoA-JNK pathway in an in vitro post-stroke depression model

Products： EQ001、 EQ003

< Page of 331 >